Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis

Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis

Yali Hu,1,2,* Kunpeng Zhang,1,* Xingyao Zhu,1,* Xiuyan Zheng,1 Chao Wang,1 Xiao Niu,1 Teng Jiang,1 Xinhua Ji,1 Weilin Zhao,1 Lijuan Pang,1 Yan Qi,1 Feng Li,1,3 Li Li,4 Zhiping Xu,4 Wenyi Gu,4 Hong Zou1 1Department of Pathology, The First Affiliated Hospital, School of Medicine, Shihezi University, K...

Full description

Saved in:
Bibliographic Details
Main Authors: Hu Y, Zhang K, Zhu X, Zheng X, Wang C, Niu X, Jiang T, Ji X, Zhao W, Pang L, Qi Y, Li F, Li L, Xu Z, Gu W, Zou H
Format: article
Language:EN
Published: Dove Medical Press 2021
Subjects:
colon cancer
nanoemulsion
paclitaxel
bez235
drug-resistance.
Medicine (General)
R5-920
Online Access:https://doaj.org/article/f243e3f03cd7469f9deb1c4c0d27bb34
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/f243e3f03cd7469f9deb1c4c0d27bb34

Similar Items